Advertisement
Screener

Royalty Pharma plc (RPRX) ROI

Royalty Pharma plc (RPRX) ROI

  • 2026-06-30: ROI 4.35%.
  • 2026-03-31: ROI 4.39%.
  • 2025-12-31: ROI 4.15%.
  • 2025-09-30: ROI 4.14%.

Complete source-backed roi history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-304.35%
2026-03-314.39%
2025-12-314.15%
2025-09-304.14%
2025-06-305.85%
2025-03-316.29%
2024-12-314.78%
2024-09-306.41%
2024-06-303.88%
2024-03-314.99%
2023-12-317.00%
2023-09-301.17%
2023-06-301.50%
2023-03-311.96%
2022-12-310.26%
2022-09-302.89%
2022-06-302.66%
2022-03-313.49%
2021-12-313.57%
2021-09-304.48%
2021-06-305.99%
2021-03-316.21%
2020-12-319.03%
2020-09-308.45%
2020-06-3016.00%

Annual ROI

DateROI
2025-12-314.13%
2024-12-314.78%
2023-12-317.00%
2022-12-310.26%
2021-12-313.57%
2020-12-316.21%
2019-12-3118.97%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Zoetis Inc. (ZTS)United States$29.045B11.38
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80